London, United Kingdom

Robin Ali

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robin Ali

Introduction

Robin Ali is a prominent inventor based in London, GB, known for his significant contributions to the field of retinal research. With a total of six patents to his name, Ali has made remarkable strides in the identification and treatment of retinal dystrophies. His work has the potential to transform the lives of individuals suffering from vision impairments.

Latest Patents

Among his latest patents is a method of identifying l/m-opsin and CRX positive cone photoreceptor cells based on specific biomarkers. This invention focuses on the identification of photoreceptors or cone photoreceptors in cell populations. The methods developed by Ali are crucial for isolating these photoreceptors, which can be utilized for transplantation and the treatment of retinal dystrophies. Another notable patent is the optimized RPE65 promoter and coding sequences, which relates to the prevention and treatment of retinal dystrophy in patients, including those with Leber congenital amaurosis (LCA).

Career Highlights

Throughout his career, Robin Ali has worked with esteemed organizations such as UCL Business Plc and Massachusetts Eye and Ear Infirmary. His innovative research and dedication to advancing retinal health have established him as a leading figure in his field.

Collaborations

Ali has collaborated with notable individuals in his research endeavors, including Alexander Smith and Michael A Sandberg. These partnerships have further enhanced the impact of his work in the scientific community.

Conclusion

Robin Ali's contributions to retinal research through his patents and collaborations highlight his commitment to improving vision health. His innovative methods and dedication to the field continue to inspire advancements in the treatment of retinal conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…